Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

IgG from Patients with Autoimmune Disease Activates Neutrophils

Lara C. Pullen, PhD  |  March 18, 2019

Abnormalities in neutrophil function play a role in autoimmune rheumatic diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Data also suggest immunoglobulin G (IgG) may be important in immunopathology, thus, many researchers have sought to better understand the interaction between IgG and neutrophils.

New data reveal a different pattern of neutrophil activation in SLE patients than in RA patients. Moreover, different autoimmune diseases have distinct patterns of IgG-mediated integrin activation and neutrophil function, which may explain disease-specific differences in vascular damage and dysfunction. Akif A. Khawaja, PhD, a research associate at University College, London, U.K., and colleagues say the research, published online in Scientific Reports, points toward novel approaches to develop new therapies.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators isolated neutrophils from 12 healthy controls, 12 SLE patients and seven RA patients. They evaluated the differences between the isolated neutrophils of each group, finding that SLE neutrophils had significantly lower rates of hydrogen peroxide (H2O2) production than healthy control neutrophils and RA neutrophils. Additionally, they found IgG more readily bound the neutrophils of SLE and RA samples than it did the neutrophils of healthy controls. Having established the difference in binding, the investigators next sought to determine if IgG modulated β1 or β2 integrin-mediated adhesion.

“Our experiments utilized immobilized fibronectin and fibrinogen, which are found in areas of tissue injury with local activation of coagulation and in regions of vascular endothelial damage where the sub-endothelial basement membrane has been exposed,” write the authors in their discussion. “Our choice of ligands has the advantage of readily allowing us to distinguish the effects of IgG on β1-mediated adhesion to ECM/VCAM-1 from the effects on αMβ2-mediated adhesion.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers found that, although both RA-IgG and SLE-IgG increased PMA-induced β1 integrin-mediated adhesion to fibronectin, only SLE-IgG enhanced αMβ2 integrin-mediated adhesion to fibrinogen.

Next, the researchers examined the modulatory effects of IgG samples from the different groups on unstimulated and PMA-induced adhesion to human umbilical cord endothelial cells. They found SLE IgG significantly enhanced both unstimulated and PMA-induced neutrophil adhesion to human umbilical cord endothelial cells.

“Integrin activation is central to leukocyte migration, therefore, we examined whether autoimmune rheumatic disease-IgG affected neutrophil adhesion to, and migration across, the endothelium,” write the authors. “Interestingly, SLE IgG, but not RA IgG, significantly augmented neutrophil adhesion to [human umbilical cord endothelial cells], while migration across an IL-8 gradient was unaffected by [autoimmune rheumatic disease]-IgG.”

The investigators then turned their attention to characterizing the ability of IgG to modulate the release of extracellular DNA and found both SLE and RA IgG caused unstimulated neutrophils to increase reactive oxygen species generation and DNA externalization. Specifically, neutrophils cultured in the presence of SLE or RA IgG spontaneously released more DNA than neutrophils cultured with healthy control IgG. However, co-culture with resting endothelium prevented IgG-mediated increase of extracellular DNA. That said, in the case of SLE IgG, the inhibition could be overcome by stimulating the endothelium with TNF-α.

Page: 1 2 | Single Page
Share: 

Filed under:Uncategorized Tagged with:Autoimmune diseasehuman immunoglobulin Gimmunoglobulin G (IgG)neutrophilneutrophils

Related Articles

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    Rheumatology Researchers Explore Role of Neutrophils in Autoimmunity

    January 19, 2016

    SAN FRANCISCO—To unravel the mysteries of how autoimmunity begins in the body and, one day, to interrupt that process, rheumatology researchers are exploring the role of neutrophils, especially when they form and release neutrophil extracellular traps (NETs). At a panel discussion on Nov. 6, 2015, held at the American College of Rheumatology’s Basic Research Conference,…

    The Mystery of IVIg

    March 8, 2012

    Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences